| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.91B | -1.8% |
| Cost of Revenue | $9.53B | -3.9% |
| R&D Expense | $1.40B | +4.9% |
| SG&A Expense | $3.20B | +0.6% |
| Interest Expense | $233.0M | +0.0% |
| Pre-tax Income | $1.27B | +16.7% |
| Income Tax | $412.0M | +171.1% |
| Net Income | $907.0M | +23.4% |
| EPS (Basic) | $1.31 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.11B | +17.5% |
| Short-term Investments | $63.0M | -35.7% |
| Accounts Receivable | $4.45B | +5.7% |
| Inventory | $5.43B | -21.3% |
| Current Assets | $15.10B | -7.2% |
| Total Assets | $40.83B | -5.0% |
| Current Liabilities | $10.39B | -0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.15B | +21.3% |
| Investing Cash Flow | -$589.0M | +70.4% |
| Financing Cash Flow | -$1.20B | -1111.1% |
| +26.0% |
| EPS (Diluted) | $1.30 | +26.2% |
| Long-term Debt |
| $1.95B |
| -14.8% |
| Stockholders' Equity | $23.79B | -5.0% |